If you need more lookups,
subscriptions start at $34 USD/month.
Per Källblad Location
Uppsala, SE
Per Källblad Work
Co-Founder and CEO @ (August 2006 - Present)
Senior Scientist @ (June 2004 - January 2007)
Founding Scientist @ (July 2000 - June 2004)
Genome Curator @ (August 1995 - October 1996)
Per Källblad Education
Stockholm University
School of Business
2004-2006
University of Cambridge
Ph.D. (Pharmacology and Drug Design)
1996-2000
University of Gothenburg
M.Sc. (Molecular Biology)
1991-1995
Université Grenoble Alpes
Cell Biology and Immunology
1993-1994
Per Källblad Skills
Drug Discovery
Drug Design
Molecular Modeling
Small Molecules
Medicinal Chemistry
Biochemistry
Protein Chemistry
Biotechnology
Molecular Biology
Drug Development
R&D
Lifesciences
Lead Change
Life Sciences
Biopharmaceuticals
Cell
High Throughput Screening
Pharmaceutical Industry
Chemistry
Research and Development (R&D)
Cell Biology
Leadership
Strategic Planning
Research and Development R&d
Per Källblad Summary
Per Källblad, based in Uppsala, SE, is currently a Co-Founder and CEO at Beactica Therapeutics. Per Källblad brings experience from previous roles at Medivir AB, De Novo Pharmaceuticals and European Bioinformatics Institute | EMBL-EBI. Per Källblad holds a 2004 - 2006 School of Business @ Stockholm University. With a robust skill set that includes Drug Discovery, Drug Design, Molecular Modeling, Small Molecules, Medicinal Chemistry and more. Per Källblad has 1 emails on RocketReach.
Looking for a different Per Källblad?
Find contact details for 700 million professionals.